Elan chief granted $5.28m share options
Elan announced this morning that Mr Kelly Martin, president and chief executive, has been granted share options in the firm to the value of $5.28m (€4.47m).
The troubled pharmaceutical company said that Martin has been granted the option to acquire one million ordinary shares in the firm as represented by American Depositary Shares.





